QuidelOrtho reports Q4 2022 revenue $866.5M, GAAP EPS $0.45; supplemental adjusted EPS $1.76 down 66% YoY

QuidelOrtho Corp

2022-FY EPS reported $9.56 revenue$3,266,000,000

Q4 GAAP EPS $0.45 vs $6.85 prior year; supplemental adjusted EPS $1.76, down 66% YoY.
Revenue $866.5M, up 36% as reported; supplemental combined revenue down 23% constant currency ex-COVID.
Full year 2022 GAAP EPS $9.56; supplemental adjusted EPS $13.80, up 1%.
Ex-COVID growth driven by Point of Care and Molecular Diagnostics; Labs weak due to China lockdowns and supply chain.
Integration cost synergies ahead of plan; 2023 guidance to be provided on conference call.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

QuidelOrtho Corp reported fourth quarter ended January 1, 2023 results: revenue $866.5 million, EPS $0.45.

Period: fourth quarter ended January 1, 2023
Revenue: $866.5 million
EPS: $0.45
Result: reported results

Exact text from the filing

language in such filing. --- EX-99.1 (EX-99.1) --- QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results Highlights • Fourth quarter revenue of $866.5 million increased by 36% as reported and 19% on a supplemental combined basis, excluding COVID-19 revenue • Full year revenue of $3.27 billion increased by 92% as reported; Supplemental

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

QuidelOrtho Corp reported full year ended January 1, 2023 results: revenue $3.27 billion, EPS $9.56.

Period: full year ended January 1, 2023
Revenue: $3.27 billion
EPS: $9.56
Result: reported results

Exact text from the filing

Full year revenue of $3.27 billion increased by 92% as reported

View on SEC.gov

Browse all earnings releases →

QuidelOrtho Corp filing history →

Source: SEC EDGAR

accession 0001906324-23-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.